# Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients

> **NCT02923804** · NA · COMPLETED · sponsor: **Pronova BioPharma** · enrollment: 172 (actual)

## Conditions studied

- Non Alcoholic Fatty Liver

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3
- **DIETARY_SUPPLEMENT:** Olive oil

## Key facts

- **NCT ID:** NCT02923804
- **Lead sponsor:** Pronova BioPharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-12-01
- **Final completion:** 2017-12-01
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2018-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02923804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02923804, "Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02923804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*